Lupin Deal Spree Continues, Looks ‘Down Under’ For Generic Growth

MUMBAI - Three weeks after it announced the acquisition of German generic firm Hormosan, the world's largest manufacturer of anti-TB drugs - Lupin - has bought a minority stake in Australian drug maker Generic Health (PharmAsia News, July 31, 2008)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Scrip